“…This induction phase is known to be characterized by intense medication protocols with high doses of cytotoxic chemotherapy agents, attempting to achieve complete remission and restore normal hematopoiesis of these patients. 35 Indeed, our preliminary study 14 and others 12,36 have shown that the induction phase is a critical time for hematological cancer treatment with more impact on oral physiological parameters such as saliva, oral microbiota, and host cell interactions. Although some previous studies have also evaluated these response variables (USF and oral streptococci load), the results are crosssectional 11,13,18 or longitudinal of short-term periods (50 days for the endpoint), 9,22,37,38 which are not able to completely evaluate the impact of cancer therapy on different follow-up time-points.…”